BACKGROUND The coronavirus disease 2019(COVID-19)pandemic disrupted healthcare in the United States.AIM To investigate COVID-19-related and non-COVID-19-related death and characteristics associated with excess death a...BACKGROUND The coronavirus disease 2019(COVID-19)pandemic disrupted healthcare in the United States.AIM To investigate COVID-19-related and non-COVID-19-related death and characteristics associated with excess death among inflammatory bowel disease(IBD)decedents.METHODS We performed a register-based study using data from the National Vital Statistics System,which reports death data from over 99%of the United States population,from January 1,2006 through December 31,2021.IBD-related deaths among adults 25 years and older were stratified by age,sex,race/ethnicity,place of death,and primary cause of death.Predicted and actual age-standardized mortality rates(ASMRs)per 100000 persons were compared.RESULTS 49782 IBD-related deaths occurred during the study period.Non-COVID-19-related deaths increased by 13.14%in 2020 and 18.12%in 2021[2020 ASMR:1.55 actual vs 1.37 predicted,95%confidence interval(CI):1.26-1.49;2021 ASMR:1.63 actual vs 1.38 predicted,95%CI:1.26-1.49].In 2020,non-COVID-19-related mortality increased by 17.65%in ulcerative colitis(UC)patients between the ages of 25 and 65 and 36.36%in non-Hispanic black(NHB)Crohn’s disease(CD)patients.During the pandemic,deaths at home or on arrival and at medical facilities as well as deaths due to neoplasms also increased.CONCLUSION IBD patients suffered excess non-COVID-19-related death during the pandemic.Excess death was associated with younger age among UC patients,and with NHB race among CD patients.Increased death at home or on arrival and due to neoplasms suggests that delayed presentation and difficulty accessing healthcare may have led to increased IBD mortality.展开更多
Background:The impact of the coronavirus disease 2019(COVID-19)pandemic on the etiology of non-COVID-19 viral pneumonia remains to be identified.We investigated the evolution of non-COVID-19 viral pneumonia in hospita...Background:The impact of the coronavirus disease 2019(COVID-19)pandemic on the etiology of non-COVID-19 viral pneumonia remains to be identified.We investigated the evolution of non-COVID-19 viral pneumonia in hospitalized patients before and after the COVID-19 pandemic.Methods:This is a single-center retrospective study.Patients who came to West China Hospital of Sichuan Univer-sity diagnosed with non-COVID-19 viral pneumonia from January 1,2016 to December 31,2021,were included and divided into pre-and post-COVID-19 groups according to the date of the COVID-19 outbreak in China.The results of 13 viral nucleic acid tests were compared between the two groups.Results:A total of 5937 patients(3954 in the pre-COVID-19 group and 1983 in the post-COVID-19 group)were analyzed.Compared with the pre-COVID-19 group,the proportion of patients tested for respiratory non-COVID-19 viral nucleic acid was significantly increased in the post-COVID-19 group(14.78%vs.22.79%,P<0.05).However,the non-COVID-19 virus-positive rates decreased from 37.9% to 14.6% after the COVID-19 outbreak(P<0.001).Notably,non-COVID-19 viral pneumonia caused by the influenza A virus H1N1(InfAH1N1)(2009)dropped to 0%after the pandemic.The top three viruses were InfAH1N1(2009)(13.9%),human rhinovirus(7.4%),and human adenovirus(3.4%)in the pre-COVID-19 group,and human rhinovirus(3.8%),human respiratory syncytial virus(2.0%),human parainfluenza virus(1.1%)and InfAH3N2(1.1%)in the post-COVID-19 group.Conclusions:The proportion of non-COVID-19 viral pneumonia decreased significantly after the COVID-19 out-break,among which InfAH1N1(2009)pneumonia decreased the most dramatically.展开更多
目的:分析新型冠状病毒感染(COVID-19)相关心律失常的文献,探索该领域的研究现状、热点并预测未来的趋势,为后来的研究者提供借鉴。方法:选择Web of Science的核心合集数据库,每项研究都进行了文献计量和视觉分析,使用CiteSpace和VOSvie...目的:分析新型冠状病毒感染(COVID-19)相关心律失常的文献,探索该领域的研究现状、热点并预测未来的趋势,为后来的研究者提供借鉴。方法:选择Web of Science的核心合集数据库,每项研究都进行了文献计量和视觉分析,使用CiteSpace和VOSviewer软件生成知识图谱。结果:共鉴定出768篇文章,发文涉及美国、意大利和中国为首的319个国家/地区和4 366个机构,领先的研究机构是梅奥诊所和哈佛医学院。New England Journal of Medicine是该领域最常被引用的期刊。在6 687位作者中,Arbelo Elena撰写的研究最多,Guo T被共同引用的次数最多,心房纤颤是最常见的关键词。结论:随着COVID-19的暴发,对COVID-19所致新发/进行性心律失常事件的研究蓬勃发展,未来的研究者可能会对COVID-19感染后新发或遗留的快速性心律失常/缓慢性心律失常的发生机制进行进一步的探索。展开更多
文摘BACKGROUND The coronavirus disease 2019(COVID-19)pandemic disrupted healthcare in the United States.AIM To investigate COVID-19-related and non-COVID-19-related death and characteristics associated with excess death among inflammatory bowel disease(IBD)decedents.METHODS We performed a register-based study using data from the National Vital Statistics System,which reports death data from over 99%of the United States population,from January 1,2006 through December 31,2021.IBD-related deaths among adults 25 years and older were stratified by age,sex,race/ethnicity,place of death,and primary cause of death.Predicted and actual age-standardized mortality rates(ASMRs)per 100000 persons were compared.RESULTS 49782 IBD-related deaths occurred during the study period.Non-COVID-19-related deaths increased by 13.14%in 2020 and 18.12%in 2021[2020 ASMR:1.55 actual vs 1.37 predicted,95%confidence interval(CI):1.26-1.49;2021 ASMR:1.63 actual vs 1.38 predicted,95%CI:1.26-1.49].In 2020,non-COVID-19-related mortality increased by 17.65%in ulcerative colitis(UC)patients between the ages of 25 and 65 and 36.36%in non-Hispanic black(NHB)Crohn’s disease(CD)patients.During the pandemic,deaths at home or on arrival and at medical facilities as well as deaths due to neoplasms also increased.CONCLUSION IBD patients suffered excess non-COVID-19-related death during the pandemic.Excess death was associated with younger age among UC patients,and with NHB race among CD patients.Increased death at home or on arrival and due to neoplasms suggests that delayed presentation and difficulty accessing healthcare may have led to increased IBD mortality.
基金supported by the National Key Research and Development Program(grant number:2022YFC2009804)Sichuan Science and Technology Program(grant number:2021YFS0003).
文摘Background:The impact of the coronavirus disease 2019(COVID-19)pandemic on the etiology of non-COVID-19 viral pneumonia remains to be identified.We investigated the evolution of non-COVID-19 viral pneumonia in hospitalized patients before and after the COVID-19 pandemic.Methods:This is a single-center retrospective study.Patients who came to West China Hospital of Sichuan Univer-sity diagnosed with non-COVID-19 viral pneumonia from January 1,2016 to December 31,2021,were included and divided into pre-and post-COVID-19 groups according to the date of the COVID-19 outbreak in China.The results of 13 viral nucleic acid tests were compared between the two groups.Results:A total of 5937 patients(3954 in the pre-COVID-19 group and 1983 in the post-COVID-19 group)were analyzed.Compared with the pre-COVID-19 group,the proportion of patients tested for respiratory non-COVID-19 viral nucleic acid was significantly increased in the post-COVID-19 group(14.78%vs.22.79%,P<0.05).However,the non-COVID-19 virus-positive rates decreased from 37.9% to 14.6% after the COVID-19 outbreak(P<0.001).Notably,non-COVID-19 viral pneumonia caused by the influenza A virus H1N1(InfAH1N1)(2009)dropped to 0%after the pandemic.The top three viruses were InfAH1N1(2009)(13.9%),human rhinovirus(7.4%),and human adenovirus(3.4%)in the pre-COVID-19 group,and human rhinovirus(3.8%),human respiratory syncytial virus(2.0%),human parainfluenza virus(1.1%)and InfAH3N2(1.1%)in the post-COVID-19 group.Conclusions:The proportion of non-COVID-19 viral pneumonia decreased significantly after the COVID-19 out-break,among which InfAH1N1(2009)pneumonia decreased the most dramatically.
文摘目的:分析新型冠状病毒感染(COVID-19)相关心律失常的文献,探索该领域的研究现状、热点并预测未来的趋势,为后来的研究者提供借鉴。方法:选择Web of Science的核心合集数据库,每项研究都进行了文献计量和视觉分析,使用CiteSpace和VOSviewer软件生成知识图谱。结果:共鉴定出768篇文章,发文涉及美国、意大利和中国为首的319个国家/地区和4 366个机构,领先的研究机构是梅奥诊所和哈佛医学院。New England Journal of Medicine是该领域最常被引用的期刊。在6 687位作者中,Arbelo Elena撰写的研究最多,Guo T被共同引用的次数最多,心房纤颤是最常见的关键词。结论:随着COVID-19的暴发,对COVID-19所致新发/进行性心律失常事件的研究蓬勃发展,未来的研究者可能会对COVID-19感染后新发或遗留的快速性心律失常/缓慢性心律失常的发生机制进行进一步的探索。
